美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元

自选股智能写手08-14

北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股票出现异动，股价快速拉升199900.00%。截至发稿，该股报0.002美元/股，成交量201股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.26百万美元，每股收益-0.02美元，毛利-36030.00美元...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2459817020?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-14 22:16","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2459817020","market":"us","top_or_hot":-1,"title":"美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股票出现异动，股价快速拉升199900.00%。截至发稿，该股报0.002美元/股，成交量201股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.26百万美元，每股收益-0.02美元，毛利-36030.00美元...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股价飙升199900.00% 市值涨4亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-14 22:16 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股票出现异动，股价快速拉升199900.00%。截至发稿，该股报0.002美元/股，成交量201股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.26百万美元，每股收益-0.02美元，毛利-36030.00美元...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b","article_id":"2459817020","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408142216019f2ad74e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2459817020","pubTimestamp":1723644961,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.股票出现异动，股价快速拉升199900.00%。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts 、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为83.05%、66.10%、48.54%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Genprex, Inc.、Tc Biopharm  Plc，振幅分别为60.83%、58.52%、49.86%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","NAVB":"Navidea生物制药"},"translate_title":"Navidea Biopharmaceuticals, Inc. (NAVB.us) shares soared 199900.00% in the U.S. OTC market, and its market value rose by US $400 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"NAVB":0.9},"content_text":"北京时间2024年08月14日22时16分，美国OTC市场Navidea Biopharmaceuticals, Inc.（NAVB.us）股票出现异动，股价快速拉升199900.00%。截至发稿，该股报0.002美元/股，成交量201股，换手率0.00%，振幅0.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-2.26百万美元，每股收益-0.02美元，毛利-36030.00美元，市盈率-0.03倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。美国OTC市场Navidea Biopharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Newamsterdam Pharma Co Nv C/Wts (To Pur Com)、Conduit Pharmaceuticals Inc.、Geovax Labs Inc C/Wts 29/09/2025(To Pur Com)涨幅较大，Genprex, Inc.、Conduit Pharmaceuticals Inc.、Viracta Therapeutics, Inc.较为活跃，换手率分别为83.05%、66.10%、48.54%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 (To Pur Com)、Genprex, Inc.、Tc Biopharm (Holdings) Plc，振幅分别为60.83%、58.52%、49.86%。美国OTC市场Navidea Biopharmaceuticals, Inc.公司简介：Navidea Biopharmaceuticals Inc是一家专注于精准医学的生物技术公司。 其产品，精密免疫诊断剂和免疫治疗产品旨在帮助识别未发现的疾病并改善靶向治疗。 该公司的平台称为Manocept技术，旨在开发针对癌症，自身免疫性疾病和其他炎症性疾病的下一代靶向诊断和疗法。公司的产品之一是Lymphoseek，一种可定位淋巴结的放射性诊断剂。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2459817020"}